JPS6317850A
(ja)
|
1986-07-11 |
1988-01-25 |
Fuji Photo Film Co Ltd |
3−フエノキシカテコ−ル類の製造方法
|
CA2004670A1
(en)
|
1988-12-08 |
1990-06-08 |
Jan Hartog |
Anxiolytically active piperazine derivatives
|
JPH02255673A
(ja)
|
1989-03-27 |
1990-10-16 |
Fuji Photo Film Co Ltd |
4―アリールオキシー1,3―ベンゾジオキソール類およびその製造方法
|
JPH02255674A
(ja)
|
1989-03-27 |
1990-10-16 |
Fuji Photo Film Co Ltd |
4―アリールオキシ―1,3―ベンゾジオキソール類およびその製造方法
|
JPH02269352A
(ja)
|
1989-04-10 |
1990-11-02 |
Fuji Photo Film Co Ltd |
感光材料
|
JP2537682B2
(ja)
|
1989-04-21 |
1996-09-25 |
富士写真フイルム株式会社 |
3―アリ―ルオキシカテコ―ル類の製造方法
|
US5296497A
(en)
|
1989-05-16 |
1994-03-22 |
Duphar International Research B.V. |
3,4-dehydropiperidine derivatives having psychotropic activity
|
JPH03130280A
(ja)
|
1989-10-17 |
1991-06-04 |
Fuji Photo Film Co Ltd |
4―アリールオキシ―1,3―ベンゾジオキソール類の製造方法
|
JP2816492B2
(ja)
|
1990-05-23 |
1998-10-27 |
コニカ株式会社 |
ハロゲン化銀写真感光材料
|
JPH0446175A
(ja)
|
1990-06-14 |
1992-02-17 |
Fuji Photo Film Co Ltd |
5―ヒドロキシ―3,4―メチレンジオキシ安息香酸誘導体の製造法
|
JPH0641038A
(ja)
|
1992-07-17 |
1994-02-15 |
Mitsubishi Kasei Corp |
カルボン酸誘導体
|
DE4326151A1
(de)
|
1993-08-04 |
1995-02-09 |
Hoechst Ag |
Aromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen
|
US5629200A
(en)
|
1993-11-18 |
1997-05-13 |
Daicel Chemical Industries, Ltd. |
Production of optically active 2-amino-1-phenylethanol derivatives by asymetrical assimilation
|
US5514505A
(en)
|
1995-05-15 |
1996-05-07 |
Xerox Corporation |
Method for obtaining improved image contrast in migration imaging members
|
JP2000507212A
(ja)
|
1996-01-29 |
2000-06-13 |
ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
性機能不全の治療方法
|
US5968929A
(en)
|
1996-10-30 |
1999-10-19 |
Schering Corporation |
Piperazino derivatives as neurokinin antagonists
|
JPH10287654A
(ja)
|
1997-04-11 |
1998-10-27 |
Nissan Chem Ind Ltd |
ピラゾロン誘導体及び除草剤
|
CN1281335A
(zh)
|
1997-10-27 |
2001-01-24 |
科泰克斯药物股份有限公司 |
用安哌克和精神安定剂治疗精神***症
|
AU763669B2
(en)
|
1998-09-29 |
2003-07-31 |
Wyeth Holdings Corporation |
Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
|
EP1384713B1
(en)
*
|
1998-12-23 |
2008-10-15 |
SmithKline Beecham Corporation |
4-amino-azepan-3-one derivatives as protease inhibitors
|
US7977333B2
(en)
|
2000-04-20 |
2011-07-12 |
Bayer Healthcare Llc |
Substituted pyridines and pyridazines with angiogenesis inhibiting activity
|
US6451814B1
(en)
|
2000-07-17 |
2002-09-17 |
Wyeth |
Heterocyclic β-3 adrenergic receptor agonists
|
KR20080027400A
(ko)
|
2000-08-21 |
2008-03-26 |
아스트라제네카 아베 |
퀴나졸린 유도체
|
WO2002016327A1
(en)
|
2000-08-23 |
2002-02-28 |
The Procter & Gamble Company |
Benzimidazoles and analogues and their use as neutrophil inhibitors
|
PL215711B1
(pl)
|
2000-08-24 |
2014-01-31 |
Univ Pittsburgh |
Nowe zwiazki pochodne tioflawiny, sposób syntezy zwiazków i ich zastosowanie, kompozycja farmaceutyczna zawierajaca zwiazki i zastosowanie kompozycji
|
AUPR255401A0
(en)
|
2001-01-16 |
2001-02-08 |
Novogen Research Pty Ltd |
Regulation of lipids and/or bone density and compositions therefor
|
EP1368024A4
(en)
|
2001-03-16 |
2009-03-18 |
Novogen Res Pty Ltd |
TREATMENT OF RESTENOSIS
|
EP1385823B1
(en)
|
2001-04-09 |
2006-12-13 |
Chiron Corporation |
Guanidino compounds as melanocortin-4 receptor (mc4-r) agonists
|
JP4307843B2
(ja)
|
2001-04-19 |
2009-08-05 |
アストラゼネカ アクチボラグ |
キナゾリン誘導体
|
DE10148618B4
(de)
|
2001-09-25 |
2007-05-03 |
Schering Ag |
Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
DE10148617A1
(de)
|
2001-09-25 |
2003-04-24 |
Schering Ag |
Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
AUPR846401A0
(en)
|
2001-10-25 |
2001-11-15 |
Novogen Research Pty Ltd |
6-Hydroxy isoflavones, derivatives and medicaments involving same
|
EP1503986B1
(en)
|
2001-12-21 |
2015-09-30 |
Cytokinetics, Inc. |
Compositions and methods for treating heart failure
|
US7524883B2
(en)
|
2002-01-08 |
2009-04-28 |
Eisai R&D Management Co., Ltd. |
Eponemycin and epoxomicin analogs and uses thereof
|
CA2473740A1
(en)
|
2002-01-18 |
2003-07-31 |
David Solow-Cordero |
Methods of treating conditions associated with an edg receptor
|
US7196108B2
(en)
|
2002-03-08 |
2007-03-27 |
Incyte San Diego Inc. |
Bicyclic heterocycles for the treatment of diabetes and other diseases
|
MXPA04009896A
(es)
|
2002-04-09 |
2005-06-17 |
Novogen Res Pty Ltd |
Metodos terapeuticos y composiciones que implican estructuras de tipo isoflav-3-eno e isoflavano.
|
DE10219294A1
(de)
|
2002-04-25 |
2003-11-13 |
Schering Ag |
Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
RU2304580C2
(ru)
|
2002-07-29 |
2007-08-20 |
Ф.Хоффманн-Ля Рош Аг |
Новые бензодиоксолы
|
AU2002951271A0
(en)
|
2002-09-06 |
2002-09-19 |
Novogen Research Pty Ltd |
Repair of dna mutagenic damage
|
EP1542654A4
(en)
|
2002-09-23 |
2008-12-17 |
Novogen Res Pty Ltd |
TREATMENT OF PHOTOTATIOOD AND ACTINIC DETERIORATION OF THE SKIN
|
EP1648452B1
(en)
|
2003-07-28 |
2009-07-22 |
Merck Serono SA |
2-imino-4-(thio)oxo-5-polycyclovinylazolines for use as pi3 kinase inhibitors
|
AU2004276337B2
(en)
|
2003-09-24 |
2009-11-12 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
CA2546643A1
(en)
|
2003-11-18 |
2005-06-02 |
Novogen Research Pty Ltd |
Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
|
EP1686981A4
(en)
|
2003-11-19 |
2011-02-23 |
Novogen Res Pty Ltd |
COMPOSITIONS AND METHODS FOR COMBINED RADIATION THERAPY AND CHEMOTHERAPY
|
CA2553729A1
(en)
|
2004-01-16 |
2005-08-04 |
Wyeth |
Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
|
AR048528A1
(es)
|
2004-04-07 |
2006-05-03 |
Millennium Pharm Inc |
Compuestos derivados de quinolina como antagonistas del receptor de pgd2 para el tratamiento de enfermedades inflamatorias y composiciones farmacéuticas que los contienen.
|
US20050245529A1
(en)
|
2004-04-14 |
2005-11-03 |
Boehringer Ingelheim International Gmbh |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
US7846959B2
(en)
|
2004-05-07 |
2010-12-07 |
Exelixis, Inc. |
Raf modulators and methods of use
|
MXPA06013250A
(es)
|
2004-05-14 |
2007-02-28 |
Abbott Lab |
Inhibidores de quinasa como agentes terapeuticos.
|
ITMI20041347A1
(it)
|
2004-07-05 |
2004-10-05 |
Italfarmaco Spa |
Derivati di alfa-amminoacidi ad attivita'antiinfiammatoria
|
SE0401971D0
(sv)
|
2004-08-02 |
2004-08-02 |
Astrazeneca Ab |
Piperidne derivatives
|
ZA200702435B
(en)
|
2004-10-12 |
2008-06-25 |
Serono Lab |
PI3 Kinase gamma inhibitors for the treatment of anaemia
|
SE0402635D0
(sv)
|
2004-10-29 |
2004-10-29 |
Astrazeneca Ab |
Chemical compounds
|
JP2006145294A
(ja)
|
2004-11-17 |
2006-06-08 |
Univ Nagoya |
蛍光標識を行うラベル化試薬、リガンドを表面にもつ基材の製造方法及びラベル化試薬を用いた測定方法
|
US7524870B2
(en)
|
2004-12-03 |
2009-04-28 |
Hoffmann-La Roche Inc. |
Biaryloxymethylarenecarboxylic acids as glycogen synthase activators
|
CN101163468A
(zh)
|
2005-02-28 |
2008-04-16 |
卫材R&D管理有限公司 |
磺酰胺化合物的新联合用途
|
US20060223846A1
(en)
|
2005-03-08 |
2006-10-05 |
Dyatkin Alexey B |
Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
|
JP2008534565A
(ja)
|
2005-03-31 |
2008-08-28 |
アストラゼネカ アクチボラグ |
Tie2阻害活性のあるアミノピリミジン誘導体
|
CN101208329A
(zh)
|
2005-04-08 |
2008-06-25 |
拜尔药品公司 |
嘧啶衍生物及其在治疗癌症中的应用
|
DK1881823T3
(en)
|
2005-05-17 |
2015-03-02 |
Sarcode Bioscience Inc |
COMPOSITION AND PROCEDURES FOR TREATMENT OF EYE DISORDERS
|
BRPI0610144A2
(pt)
|
2005-05-25 |
2010-06-01 |
Wyeth Corp |
método de preparar um 3-cianoquinolina substituìda; composto representado pela fórmula i; e composto, representado pela fórmula ii
|
JPWO2006129609A1
(ja)
|
2005-05-30 |
2009-01-08 |
塩野義製薬株式会社 |
2−ナフチルイミノ−5,5−ジ置換−1,3−チアジン誘導体
|
AU2006252768A1
(en)
|
2005-06-02 |
2006-12-07 |
Bayer Cropscience Ag |
Phenylalkyl substituted heteroaryl devivatives
|
WO2006138418A2
(en)
|
2005-06-14 |
2006-12-28 |
President And Fellows Of Harvard College |
Improvement of cognitive performance with sirtuin activators
|
US7956050B2
(en)
|
2005-07-15 |
2011-06-07 |
Albany Molecular Research, Inc. |
Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
|
JP2009502809A
(ja)
|
2005-07-21 |
2009-01-29 |
パラテック ファーマシューティカルズ インコーポレイテッド |
10−置換テトラサイクリンおよびその使用方法
|
WO2007019083A1
(en)
|
2005-08-04 |
2007-02-15 |
Janssen Pharmaceutica N.V. |
Pyrimidine compounds as serotonin receptor modulators
|
WO2007020936A1
(ja)
|
2005-08-17 |
2007-02-22 |
Daiichi Sankyo Company, Limited |
抗真菌作用二環性複素環化合物
|
WO2007081630A2
(en)
|
2005-12-21 |
2007-07-19 |
Janssen Pharmaceutica, N.V. |
Substituted pyrimidinyl kinase inhibitors
|
CN101007798B
(zh)
|
2006-01-24 |
2011-01-26 |
中国人民解放军军事医学科学院毒物药物研究所 |
苯并间二氧杂环戊烯衍生物及其制备方法和医药用途
|
MX2008011857A
(es)
|
2006-03-23 |
2008-12-15 |
Prolysis Ltd |
Agentes antibacterianos.
|
PT2032575E
(pt)
|
2006-05-30 |
2010-07-09 |
Neurosearch As |
NOVO DERIVADO DE 1,4-DIAZA-BICICLO[3,2,2]NONIL-OXADIAZOLILO E A SUA APLICAÃO MéDICA
|
US20100035877A1
(en)
|
2006-06-26 |
2010-02-11 |
Katz David M |
Methods and compositions for treating pathologies associated with bdnf signaling
|
WO2008029168A2
(en)
|
2006-09-08 |
2008-03-13 |
Summit Corporation Plc |
Treatment of duchenne muscular dystrophy
|
EP2084141A4
(en)
|
2006-10-30 |
2010-07-21 |
Novogen Res Pty Ltd |
PREVENTION AND REVERSION OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
|
RU2333211C1
(ru)
|
2006-11-01 |
2008-09-10 |
Институт физиологически активных веществ Российской Академии наук |
N,n`-замещенные 3, 7-диазабицикло[3.3.1]нонаны, обладающие фармакологической активностью, фармацевтические композиции на их основе и способ их применения
|
JP2010526825A
(ja)
|
2007-05-10 |
2010-08-05 |
エーエムアール テクノロジー インコーポレイテッド |
アリール置換およびヘテロアリール置換テトラヒドロベンゾ−1,4−ジアゼピンならびにノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを遮断するためのその使用
|
BRPI0704074B8
(pt)
|
2007-08-29 |
2021-05-25 |
Univ Estadual Paulista Julio De Mesquita Filho Unesp |
derivados piperidínicos da (-)-cassina e (-)-spectalina, composições farmacêuticas contendo os mesmos e processos para sua preparação
|
ES2830024T3
(es)
|
2007-10-19 |
2021-06-02 |
Novartis Ag |
Composiciones y métodos para el tratamiento del edema macular
|
KR20170051521A
(ko)
|
2008-04-16 |
2017-05-11 |
포톨라 파마슈티컬스, 인코포레이티드 |
syk 또는 JAK 키나제 억제제로서의 2,6-디아미노-피리미딘-5-일-카르복스아미드
|
JP5530430B2
(ja)
|
2008-06-23 |
2014-06-25 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Ccr2のピペリジルアクリルアミドアンタゴニスト
|
WO2010019772A2
(en)
|
2008-08-14 |
2010-02-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Oxadiazole-2-oxides as antischistosomal agents
|
JP2010254629A
(ja)
|
2009-04-27 |
2010-11-11 |
Bayer Cropscience Ag |
光学活性アゾリン誘導体
|
US9206173B2
(en)
|
2009-05-28 |
2015-12-08 |
Otsuka Pharmaceutical Co., Ltd. |
Heterocyclic compounds for the treatment of stress-related conditions
|
AU2010270153A1
(en)
|
2009-07-10 |
2012-02-02 |
Vivalis |
Substituted pyrrolidinone as inhibitors of hepatitis C NS5B polymerase, the pharmaceutical composition thereof and their therapeutic use
|
RU2417082C2
(ru)
|
2009-07-14 |
2011-04-27 |
Учреждение Российской Академии Наук Институт Физиологически Активных Веществ Ран (Ифав Ран) |
Средство для восстановления утраченной памяти в норме и патологии у пациентов всех возрастных групп на основе n, n'-замещенных 3, 7-диазабицикло[3.3.1]нонанов, фармацевтическая композиция на его основе и способ ее применения
|
US9150813B2
(en)
|
2009-12-17 |
2015-10-06 |
The Lubrizol Corporation |
Lubricating composition containing an aromatic compound
|
AU2011209051B2
(en)
|
2010-01-27 |
2015-01-15 |
AB Pharma Ltd. |
Polyheterocyclic compounds highly potent as HCV inhibitors
|
CN101851218B
(zh)
|
2010-04-27 |
2014-10-15 |
沈阳药科大学 |
4,5-二取代芳基异硒唑类衍生物及其用途
|
EP2580215A4
(en)
|
2010-06-10 |
2014-01-15 |
Afraxis Holdings Inc |
8- (HETEROCYCYL) PYRIDO [2,3-D] PYRIMIDIN-7 (8H) -ONES FOR THE TREATMENT OF CNS DISORDERS
|
CA2801182A1
(en)
|
2010-06-16 |
2011-12-22 |
Metabolex, Inc. |
Gpr120 receptor agonists and uses thereof
|
WO2012013725A1
(en)
|
2010-07-28 |
2012-02-02 |
Medizinische Universität Wien |
Vinylogous chalcone derivatives and their medical use
|
US9132136B2
(en)
|
2010-08-02 |
2015-09-15 |
Hoffmann-La Roche Inc. |
Pharmaceutical combination
|
TW201225957A
(en)
|
2010-09-17 |
2012-07-01 |
Taisho Pharmaceutical Co Ltd |
Glycine transporter inhibitor
|
WO2012045196A1
(en)
|
2010-10-09 |
2012-04-12 |
Abbott Laboratories |
Phosphoglycerate kinase inhibitors
|
US8802673B2
(en)
|
2011-03-24 |
2014-08-12 |
Hoffmann-La Roche Inc |
Heterocyclic amine derivatives
|
WO2013025484A1
(en)
|
2011-08-12 |
2013-02-21 |
Lapchak Paul A |
Polyphenol analogs to treat ischemia
|
US8791108B2
(en)
|
2011-08-18 |
2014-07-29 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
WO2013065835A1
(ja)
|
2011-11-04 |
2013-05-10 |
味の素株式会社 |
糖尿病治療用医薬組成物
|
CA2862289C
(en)
|
2012-02-10 |
2019-11-26 |
Constellation Pharmaceuticals, Inc. |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
US9475783B2
(en)
|
2012-03-21 |
2016-10-25 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
RU2509770C2
(ru)
|
2012-06-22 |
2014-03-20 |
Общество с ограниченной ответственностью "Молекулярные Технологии" |
Новые химические соединения производные 2,4-диамино-1,3,5-триазина для профилактики и лечения заболеваний человека и животных
|
BR112015004284A2
(pt)
|
2012-08-30 |
2017-07-04 |
Nippon Shinyaku Co Ltd |
derivado de piridina e medicina
|
CA2900335C
(en)
|
2012-10-22 |
2021-10-26 |
City Of Hope |
Synthetic analogs of epipolythiodioxopiperazines and uses thereof
|
KR20150127249A
(ko)
|
2013-03-13 |
2015-11-16 |
보스톤 바이오메디칼, 인크. |
암 치료를 위한 암 줄기세포 경로 키나아제의 저해제로서 3-(아릴 또는 헤테로아릴)메틸렌인돌린-2-온 유도체
|
EP2991963B1
(en)
|
2013-04-30 |
2021-07-07 |
Heinrich-Heine-Universität Düsseldorf |
Inhibitors of nhr2 and/or runx1/eto-tetramerization
|
KR20150027922A
(ko)
|
2013-09-04 |
2015-03-13 |
주식회사 대웅제약 |
신규한 항진균성 피리디닐하이드라자이드 유도체
|
CN105518014B
(zh)
|
2013-09-09 |
2018-03-23 |
上海研健新药研发有限公司 |
C‑芳基葡糖苷衍生物、其制备方法及其在医药上的应用
|
WO2015069110A1
(en)
|
2013-11-07 |
2015-05-14 |
Aapa B.V. |
Multiple d2 a(nta)gonists/h3 antagonists for treatment of cns-related disorders
|
SI3121175T1
(sl)
*
|
2014-03-17 |
2020-07-31 |
Daiichi Sankyo Company, Limited |
Derivati 1,3-benzodioksola kot EZH1 in/ali EZH2 inhibitorji
|
AP2016009605A0
(en)
|
2014-06-17 |
2016-12-31 |
Pfizer |
Substituted dihydroisoquinolinone compounds
|
AU2015313829B2
(en)
|
2014-09-11 |
2020-07-23 |
Piramal Enterprises Limited |
Fused heterocyclic compounds as GPR120 agonists
|
US20180037568A1
(en)
*
|
2015-02-13 |
2018-02-08 |
Constellation Pharmaceuticals, Inc. |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
AU2016299614B2
(en)
|
2015-07-30 |
2020-05-07 |
Daiichi Sankyo Company, Limited |
Agent for treating and/or preventing adult T cell leukemia/lymphoma
|
DK3378859T3
(da)
|
2015-11-19 |
2020-01-20 |
Jiangsu Hengrui Medicine Co |
Benzofuranderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf i medicin
|
ES2797904T3
(es)
|
2016-01-13 |
2020-12-04 |
Gruenenthal Gmbh |
Derivados de 3-((hetero)aril)alquil-8-amino-2-oxo-1,3-diazaespiro-[4.5]-decano
|
KR102486298B1
(ko)
|
2016-02-09 |
2023-01-06 |
인벤티스바이오 엘엘씨 |
인돌아민-2,3-디옥시게나아제(ido)의 억제제
|
US20170355708A1
(en)
*
|
2016-06-09 |
2017-12-14 |
Cadent Therapeutics, Inc. |
Potassium channel modulators
|
US20180016260A1
(en)
|
2016-07-14 |
2018-01-18 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
CN106727549A
(zh)
|
2016-11-26 |
2017-05-31 |
李�荣 |
一种治疗抑郁症的药物
|
AU2018210099A1
(en)
|
2017-01-19 |
2019-08-15 |
Daiichi Sankyo Company, Limited |
Pharmaceutical composition used for treatment of HTLV-1-associated myelopathy
|
US11466020B2
(en)
|
2017-03-17 |
2022-10-11 |
Cornell University |
Compounds and compositions for inhibition and elimination of Zika infection and uses for same
|
AU2018271990A1
(en)
|
2017-05-25 |
2019-12-12 |
Araxes Pharma Llc |
Covalent inhibitors of KRAS
|
EP3700527A4
(en)
|
2017-10-25 |
2021-03-10 |
Children's Medical Center Corporation |
PAPD5 INHIBITORS AND THEIR METHODS OF USE
|
GB201718285D0
(en)
|
2017-11-03 |
2017-12-20 |
Discuva Ltd |
Antibacterial Compounds
|
JP2021035913A
(ja)
|
2017-12-21 |
2021-03-04 |
石原産業株式会社 |
N−メトキシアミド化合物又はその塩、及びそれらを含有する農園芸用殺菌剤
|
US20210177781A9
(en)
|
2018-01-12 |
2021-06-17 |
KDAc Therapeutics, Inc. |
Combination of a selective histone deacetylase 3 (hdac3) inhibitor and an immunotherapy agent for the treatment of cancer
|
JP2019168611A
(ja)
|
2018-03-23 |
2019-10-03 |
株式会社Adeka |
光学フィルタ
|
US20210093591A1
(en)
|
2018-03-30 |
2021-04-01 |
San Diego State University (SDSU) Foundation, dba San Diego State University Research Foundation |
Methods for mitigating and preventing proteostasis-based injuries
|
BR112020021194A2
(pt)
|
2018-04-18 |
2021-03-23 |
Constallation Pharmaceuticals, Inc. |
moduladores de enzimas modificadoras de metila, composições e usos dos mesmos
|